205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.65%
Revenue growth above 1.5x LSCC's 0.14%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.39%
Gross profit growth 1.25-1.5x LSCC's 4.04%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
44.97%
EBIT growth 50-75% of LSCC's 87.54%. Martin Whitman would suspect suboptimal resource allocation.
40.47%
Operating income growth under 50% of LSCC's 87.54%. Michael Burry would be concerned about deeper cost or sales issues.
75.78%
Net income growth comparable to LSCC's 82.66%. Walter Schloss might see both following similar market or cost trajectories.
78.95%
EPS growth similar to LSCC's 83.09%. Walter Schloss would assume both have parallel share structures and profit trends.
76.32%
Similar diluted EPS growth to LSCC's 83.09%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.88%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.37%
Dividend growth of 0.37% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
78.07%
OCF growth under 50% of LSCC's 528.03%. Michael Burry might suspect questionable revenue recognition or rising costs.
98.87%
FCF growth under 50% of LSCC's 232.90%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
128.08%
10Y revenue/share CAGR above 1.5x LSCC's 19.33%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
16.05%
5Y revenue/share CAGR at 75-90% of LSCC's 19.79%. Bill Ackman would encourage strategies to match competitor’s pace.
30.73%
3Y revenue/share CAGR at 50-75% of LSCC's 42.58%. Martin Whitman would question if the firm lags behind competitor innovations.
221.77%
10Y OCF/share CAGR above 1.5x LSCC's 9.20%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-1.55%
Negative 5Y OCF/share CAGR while LSCC is at 225.81%. Joel Greenblatt would question the firm’s operational model or cost structure.
60.07%
Positive 3Y OCF/share CAGR while LSCC is negative. John Neff might see a big short-term edge in operational efficiency.
530.73%
Net income/share CAGR above 1.5x LSCC's 85.71% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
26.69%
5Y net income/share CAGR at 50-75% of LSCC's 51.81%. Martin Whitman might see a shortfall in operational efficiency or brand power.
61.84%
3Y net income/share CAGR 1.25-1.5x LSCC's 47.79%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
55.49%
Positive growth while LSCC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
28.39%
Positive 5Y equity/share CAGR while LSCC is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
34.19%
3Y equity/share CAGR at 50-75% of LSCC's 46.86%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
707.91%
Dividend/share CAGR of 707.91% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
113.40%
Dividend/share CAGR of 113.40% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
56.13%
3Y dividend/share CAGR of 56.13% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-0.37%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.96%
Inventory is declining while LSCC stands at 0.84%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.09%
Positive asset growth while LSCC is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.10%
Positive BV/share change while LSCC is negative. John Neff sees a clear edge over a competitor losing equity.
20.99%
Debt growth of 20.99% while LSCC is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-3.54%
Our R&D shrinks while LSCC invests at 5.59%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.66%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.